Cargando…

Unveiling 7-Hydroxymitragynine as the Key Active Metabolite of Mitragynine and the Promise for Creating Novel Pain Relievers

Detalles Bibliográficos
Autores principales:	Spetea, Mariana, Schmidhammer, Helmut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598155/ https://www.ncbi.nlm.nih.gov/pubmed/31263752 http://dx.doi.org/10.1021/acscentsci.9b00462

Ejemplares similares

In silico investigation of mitragynine and 7-hydroxymitragynine metabolism
por: Limpanuparb, Taweetham, et al.
Publicado: (2019)

7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects
por: Kruegel, Andrew C., et al.
Publicado: (2019)

Effects of mitragynine and 7-hydroxymitragynine (the alkaloids of Mitragyna speciosa Korth) on 4-methylumbelliferone glucuronidation in rat and human liver microsomes and recombinant human uridine 5’-diphospho-glucuronosyltransferase isoforms
por: Haron, Munirah, et al.
Publicado: (2015)

The respiratory depressant effects of mitragynine are limited by its conversion to 7‐OH mitragynine
por: Hill, Rob, et al.
Publicado: (2022)

Development of 5-Substituted N-Methylmorphinan-6-ones as Potent Opioid Analgesics with Improved Side-Effect Profile
por: Schmidhammer, Helmut, et al.
Publicado: (2012)

Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery
por: Spetea, Mariana, et al.
Publicado: (2020)

Recent Chemical and Pharmacological Developments on 14-Oxygenated-N-methylmorphinan-6-ones
por: Spetea, Mariana, et al.
Publicado: (2021)

Peripheralization Strategies Applied to Morphinans and Implications for Improved Treatment of Pain
por: Schmidhammer, Helmut, et al.
Publicado: (2023)

Pharmacokinetics of mitragynine in man
por: Trakulsrichai, Satariya, et al.
Publicado: (2015)

5-Benzyl substituted 14-methoxymetopon, a high affinity μ opioid receptor agonist with potent antinociceptive activity in mice
por: Spetea, Mariana, et al.
Publicado: (2008)

Molecular Docking, Molecular Dynamics, and Structure–Activity Relationship Explorations of 14-Oxygenated N-Methylmorphinan-6-ones as Potent μ-Opioid Receptor Agonists
por: Noha, Stefan M., et al.
Publicado: (2017)

Directed Biosynthesis of Mitragynine Stereoisomers
por: Schotte, Carsten, et al.
Publicado: (2023)

μ Opioid receptor: novel antagonists and structural modeling
por: Kaserer, Teresa, et al.
Publicado: (2016)

Synthesis, opioid receptor binding profile and SAR studies of 14-alkoxy-substituted indolo- and benzofuromorphinans
por: Staaf, Alexander, et al.
Publicado: (2008)

Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities
por: Schmidhammer, Helmut, et al.
Publicado: (2020)

Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors
por: Puls, Kristina, et al.
Publicado: (2022)

A ligand-based 3D pharmacophore model for the μ opioid receptor: application to the morphinan class of opioids
por: Asim, Muhammad Faheem, et al.
Publicado: (2010)

Efficacy of systemic HS-198, an analogue of oxymorphone, on cancer pain-related behaviour in mice
por: Asim, Muhammad F, et al.
Publicado: (2011)

Development of novel N-methyl and N-allyl-substituted oxazolomorphinans and their interaction with opioid receptors
por: Sipos, Attila, et al.
Publicado: (2011)

Comparison of physicochemical properties and biological activities of opioid morphinans interacting with mu opioid receptors
por: Asim, Muhammad F, et al.
Publicado: (2008)

In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
por: Lattanzi, Roberta, et al.
Publicado: (2018)

In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel μ opioid analgesic with reduced propensity to alter motor function
por: Spetea, Mariana, et al.
Publicado: (2010)

Identification of novel ligands interacting with kappa opioid receptors
por: Spetea, Mariana, et al.
Publicado: (2011)

Kratom (Mitragynine) Ingestion Requiring Naloxone Reversal
por: Overbeek, Daniel L., et al.
Publicado: (2019)

Influence of the 14-alkoxy group and the substitution in position 5 in N-methyl-14-alkoxymorphinan-6-ones on in vitro and in vivo pharmacological activities
por: Haddou, Tanila Ben, et al.
Publicado: (2012)

Mitragynine Attenuates Withdrawal Syndrome in Morphine-Withdrawn Zebrafish
por: Khor, Beng-Siang, et al.
Publicado: (2011)

Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
por: Hassan, Rahimah, et al.
Publicado: (2021)

Mitragynine inhibits hippocampus neuroplasticity and its molecular mechanism
por: Yunusa, Suleiman, et al.
Publicado: (2023)

Introduction of a 6-cyano group in 14-oxygenated N-methylmorphinans influences in vitro and in vivo pharmacological activities
por: Follia, Valeria, et al.
Publicado: (2011)

The Combination of Mitragynine and Morphine Prevents the Development of Morphine Tolerance in Mice
por: Fakurazi, Sharida, et al.
Publicado: (2013)

The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review
por: Karunakaran, Thiruventhan, et al.
Publicado: (2022)

Respiratory effects of oral mitragynine and oxycodone in a rodent model
por: Henningfield, Jack E., et al.
Publicado: (2022)

Discovery and biological evaluation of a diphenethylamine derivative (HS665), a highly potent and selective κ opioid receptor agonist
por: Spetea, Mariana, et al.
Publicado: (2012)

Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity
por: Ben Haddou, Tanila, et al.
Publicado: (2014)

Highly Potent and Selective New Diphenethylamines Interacting with the κ-Opioid Receptor: Synthesis, Pharmacology, and Structure–Activity Relationships
por: Erli, Filippo, et al.
Publicado: (2017)

Inhibitory effect of mitragynine on human cytochrome P450 enzyme activities
por: Hanapi, N. A., et al.
Publicado: (2013)

Drug testing for mitragynine and kratom: Analytical challenges and medico‐legal considerations
por: Helander, Anders, et al.
Publicado: (2022)

Biological, pharmacological and immunological activities of novel 6-amino-acid-substituted 14-alkoxy-N-methylmorphinans
por: Guerrieri, Elena, et al.
Publicado: (2011)

Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists
por: Dumitrascuta, Maria, et al.
Publicado: (2017)

Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine
por: Hassan, Rahimah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_arr0u3usorsl2o7nii5b32m2sb